Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chelationcare warning letter

This article was originally published in The Tan Sheet

Executive Summary

Anti-THRAX anthrax vaccine alternative and Viral Immune alternative immunizations "are considered drugs because the therapeutic claims that are shown on your websites establish their intended use as drugs," FDA tells Chelationcare Centers USA in a Sept. 30 warning letter. Both products, which are indicated for smallpox, measles and encephalitis viruses, "make numerous effectiveness claims, but they lack descriptions of the risks, warnings and contraindications" related to the products. Websites advertising products are currently down...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel